Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Actinium Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 70.3K | Dec 28, 2023 | Direct | ||
Adverum Biotechnologies, Inc. | Director | Stock Option (Right to Buy) | 10.5K | Jun 17, 2024 | Direct | ||
Adverum Biotechnologies, Inc. | Director | No securities owned. | 0 | Nov 3, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADVM | Adverum Biotechnologies, Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
ATNM | Actinium Pharmaceuticals, Inc. | Dec 28, 2023 | 1 | $0 | 4 | Dec 29, 2023 | Director |
ADVM | Adverum Biotechnologies, Inc. | Nov 3, 2023 | 1 | $0 | 4 | Nov 6, 2023 | Director |
ADVM | Adverum Biotechnologies, Inc. | Nov 3, 2023 | 0 | $0 | 3 | Nov 6, 2023 | Director |
ATNM | Actinium Pharmaceuticals, Inc. | Jul 1, 2022 | 1 | $0 | 4 | Jul 1, 2022 | Director |
ATNM | Actinium Pharmaceuticals, Inc. | Sep 1, 2021 | 1 | $0 | 4 | Sep 3, 2021 | Director |